Johnson & Johnson’s JNJ stock has been trading above its 50-day and 200-day simple moving averages (SMAs) since mid-June. It achieved the golden cross in mid-July, after the company announced strong second-quarter 2025 results and raised sales and EPS guidance for the year.The 50-day moving average is a short-term indicator,...